Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1995 Jul 15;309(Pt 2):689–693. doi: 10.1042/bj3090689

Over-expression and characterization of active recombinant rat liver carnitine palmitoyltransferase II using baculovirus.

T M Johnson 1, W R Mann 1, C J Dragland 1, R C Anderson 1, G M Nemecek 1, P A Bell 1
PMCID: PMC1135785  PMID: 7626037

Abstract

The cDNA encoding rat liver carnitine palmitoyltransferase II (CPT-II) was heterologously expressed using a recombinant baculovirus/insect cell system. Unlike Escherichia coli, the baculovirus-infected insect cells expressed mostly soluble active recombinant CPT-II (rCPT-II). CPT activity from crude lysates of recombinant baculovirus-infected insect cells was maximal between 50 and 72 h post-infection, with a peak specific activity of 100-200 times that found in the mock- or wild-type-infected control lysates. Milligram quantities (up to 1.8 mg/l of culture) of active rCPT-II were chromatographically purified from large-scale cultures of insect cells infected with the recombinant baculovirus. The rCPT-II was found to be: (1) similar in size to the native rat liver enzyme (approximately 70 kDa) as judged by SDS/PAGE; (2) immunoreactive with a polyclonal serum raised against rat liver CPT-II; and (3) not glycosylated. Kinetic analysis of soluble rCPT-II revealed Km values for carnitine and palmitoyl-CoA of 950 +/- 27 microM and 34 +/- 5.6 microM respectively.

Full text

PDF
689

Images in this article

691Figure 1
on p.691
691Figure 2
on p.691
692Figure 4
on p.692

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bieber L. L., Fiol C. Purification and assay of carnitine acyltransferases. Methods Enzymol. 1986;123:276–284. doi: 10.1016/s0076-6879(86)23031-1. [DOI] [PubMed] [Google Scholar]
  2. Bonnefont J. P., Haas R., Wolff J., Thuy L. P., Buchta R., Carroll J. E., Saudubray J. M., Demaugre F., Nyhan W. L. Deficiency of carnitine palmitoyltransferase I. J Child Neurol. 1989 Jul;4(3):198–203. doi: 10.1177/088307388900400310. [DOI] [PubMed] [Google Scholar]
  3. Bougnères P. F., Saudubray J. M., Marsac C., Bernard O., Odièvre M., Girard J. Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J Pediatr. 1981 May;98(5):742–746. doi: 10.1016/s0022-3476(81)80834-7. [DOI] [PubMed] [Google Scholar]
  4. Brady P. S., Brady L. J. Regulation of carnitine palmitoyltransferase in vivo by glucagon and insulin. Biochem J. 1989 Mar 15;258(3):677–682. doi: 10.1042/bj2580677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chase J. F., Tubbs P. K. Specific alkylation of a histidine residue in carnitine acetyltransferase by bromoacetyl-L-carnitine. Biochem J. 1970 Feb;116(4):713–720. doi: 10.1042/bj1160713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clarke P. R., Bieber L. L. Isolation and purification of mitochondrial carnitine octanoyltransferase activities from beef heart. J Biol Chem. 1981 Oct 10;256(19):9861–9868. [PubMed] [Google Scholar]
  7. Cook G. A., Gamble M. S. Regulation of carnitine palmitoyltransferase by insulin results in decreased activity and decreased apparent Ki values for malonyl-CoA. J Biol Chem. 1987 Feb 15;262(5):2050–2055. [PubMed] [Google Scholar]
  8. Declercq P. E., Falck J. R., Kuwajima M., Tyminski H., Foster D. W., McGarry J. D. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors. J Biol Chem. 1987 Jul 15;262(20):9812–9821. [PubMed] [Google Scholar]
  9. Declercq P. E., Venincasa M. D., Mills S. E., Foster D. W., McGarry J. D. Interaction of malonyl-CoA and 2-tetradecylglycidyl-CoA with mitochondrial carnitine palmitoyltransferase I. J Biol Chem. 1985 Oct 15;260(23):12516–12522. [PubMed] [Google Scholar]
  10. Demaugre F., Bonnefont J. P., Colonna M., Cepanec C., Leroux J. P., Saudubray J. M. Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies. J Clin Invest. 1991 Mar;87(3):859–864. doi: 10.1172/JCI115090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Edwards M. R., Bird M. I., Saggerson E. D. Effects of DL-2-bromopalmitoyl-CoA and bromoacetyl-CoA in rat liver and heart mitochondria. Inhibition of carnitine palmitoyltransferase and displacement of [14C]malonyl-CoA from mitochondrial binding sites. Biochem J. 1985 Aug 15;230(1):169–179. doi: 10.1042/bj2300169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Finocchiaro G., Taroni F., Rocchi M., Martin A. L., Colombo I., Tarelli G. T., DiDonato S. cDNA cloning, sequence analysis, and chromosomal localization of the gene for human carnitine palmitoyltransferase. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):661–665. doi: 10.1073/pnas.88.2.661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fiol C. J., Bieber L. L. Effects of octylglucoside and triton X-100 on the kinetics and specificity of carnitine palmitoyltransferase. Lipids. 1988 Feb;23(2):120–125. doi: 10.1007/BF02535291. [DOI] [PubMed] [Google Scholar]
  14. Fiol C. J., Bieber L. L. Sigmoid kinetics of purified beef heart mitochondrial carnitine palmitoyltransferase. Effect of pH and malonyl-CoA. J Biol Chem. 1984 Nov 10;259(21):13084–13088. [PubMed] [Google Scholar]
  15. Foley J. E. Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus. Diabetes Care. 1992 Jun;15(6):773–784. doi: 10.2337/diacare.15.6.773. [DOI] [PubMed] [Google Scholar]
  16. Gamble M. S., Cook G. A. Alteration of the apparent Ki of carnitine palmitoyltransferase for malonyl-CoA by the diabetic state and reversal by insulin. J Biol Chem. 1985 Aug 15;260(17):9516–9519. [PubMed] [Google Scholar]
  17. Ishii S., Ishii H., Watanabe T., Suga T. Purification and properties of peroxisomal carnitine palmitoyltransferase in chick embryo liver. Biochim Biophys Acta. 1987 Jun 22;924(3):530–542. doi: 10.1016/0304-4165(87)90169-3. [DOI] [PubMed] [Google Scholar]
  18. Johnson T. M., Kocher H. P., Anderson R. C., Nemecek G. M. Cloning, sequencing and heterologous expression of a cDNA encoding pigeon liver carnitine acetyltransferase. Biochem J. 1995 Jan 15;305(Pt 2):439–444. doi: 10.1042/bj3050439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Johnson T. M., Li J. K. Heterologous expression and characterization of an active lignin peroxidase from Phanerochaete chrysosporium using recombinant baculovirus. Arch Biochem Biophys. 1991 Dec;291(2):371–378. doi: 10.1016/0003-9861(91)90148-c. [DOI] [PubMed] [Google Scholar]
  20. Kiorpes T. C., Hoerr D., Ho W., Weaner L. E., Inman M. G., Tutwiler G. F. Identification of 2-tetradecylglycidyl coenzyme A as the active form of methyl 2-tetradecylglycidate (methyl palmoxirate) and its characterization as an irreversible, active site-directed inhibitor of carnitine palmitoyltransferase A in isolated rat liver mitochondria. J Biol Chem. 1984 Aug 10;259(15):9750–9755. [PubMed] [Google Scholar]
  21. Lilly K., Chung C., Kerner J., VanRenterghem R., Bieber L. L. Effect of etomoxiryl-CoA on different carnitine acyltransferases. Biochem Pharmacol. 1992 Jan 22;43(2):353–361. doi: 10.1016/0006-2952(92)90298-w. [DOI] [PubMed] [Google Scholar]
  22. McGarry J. D., Foster D. W. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem. 1980;49:395–420. doi: 10.1146/annurev.bi.49.070180.002143. [DOI] [PubMed] [Google Scholar]
  23. McGarry J. D., Leatherman G. F., Foster D. W. Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. J Biol Chem. 1978 Jun 25;253(12):4128–4136. [PubMed] [Google Scholar]
  24. McGarry J. D., Mills S. E., Long C. S., Foster D. W. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J. 1983 Jul 15;214(1):21–28. doi: 10.1042/bj2140021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. McGarry J. D., Sen A., Esser V., Woeltje K. F., Weis B., Foster D. W. New insights into the mitochondrial carnitine palmitoyltransferase enzyme system. Biochimie. 1991 Jan;73(1):77–84. doi: 10.1016/0300-9084(91)90078-f. [DOI] [PubMed] [Google Scholar]
  26. Miyazawa S., Ozasa H., Furuta S., Osumi T., Hashimoto T. Purification and properties of carnitine acetyltransferase from rat liver. J Biochem. 1983 Feb;93(2):439–451. doi: 10.1093/oxfordjournals.jbchem.a134198. [DOI] [PubMed] [Google Scholar]
  27. Miyazawa S., Ozasa H., Osumi T., Hashimoto T. Purification and properties of carnitine octanoyltransferase and carnitine palmitoyltransferase from rat liver. J Biochem. 1983 Aug;94(2):529–542. doi: 10.1093/oxfordjournals.jbchem.a134384. [DOI] [PubMed] [Google Scholar]
  28. Murthy M. S., Pande S. V. Some differences in the properties of carnitine palmitoyltransferase activities of the mitochondrial outer and inner membranes. Biochem J. 1987 Dec 15;248(3):727–733. doi: 10.1042/bj2480727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Nic a' Bháird N., Kumaravel G., Gandour R. D., Krueger M. J., Ramsay R. R. Comparison of the active sites of the purified carnitine acyltransferases from peroxisomes and mitochondria by using a reaction-intermediate analogue. Biochem J. 1993 Sep 15;294(Pt 3):645–651. doi: 10.1042/bj2940645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ratheiser K., Schneeweiss B., Waldhäusl W., Fasching P., Korn A., Nowotny P., Rohac M., Wolf H. P. Inhibition by etomoxir of carnitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus. Metabolism. 1991 Nov;40(11):1185–1190. doi: 10.1016/0026-0495(91)90214-h. [DOI] [PubMed] [Google Scholar]
  31. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Taroni F., Verderio E., Fiorucci S., Cavadini P., Finocchiaro G., Uziel G., Lamantea E., Gellera C., DiDonato S. Molecular characterization of inherited carnitine palmitoyltransferase II deficiency. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8429–8433. doi: 10.1073/pnas.89.18.8429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tutwiler G. F., Brentzel H. J., Kiorpes T. C. Inhibition of mitochondrial carnitine palmitoyl transferase A in vivo with methyl 2-tetradecylglycidate (methyl palmoxirate) and its relationship to ketonemia and glycemia. Proc Soc Exp Biol Med. 1985 Feb;178(2):288–296. doi: 10.3181/00379727-178-42012. [DOI] [PubMed] [Google Scholar]
  34. Woeltje K. F., Esser V., Weis B. C., Sen A., Cox W. F., McPhaul M. J., Slaughter C. A., Foster D. W., McGarry J. D. Cloning, sequencing, and expression of a cDNA encoding rat liver mitochondrial carnitine palmitoyltransferase II. J Biol Chem. 1990 Jun 25;265(18):10720–10725. [PubMed] [Google Scholar]
  35. Woeltje K. F., Kuwajima M., Foster D. W., McGarry J. D. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. II. Use of detergents and antibodies. J Biol Chem. 1987 Jul 15;262(20):9822–9827. [PubMed] [Google Scholar]
  36. Wolf H. P., Eistetter K., Ludwig G. Phenylalkyloxirane carboxylic acids, a new class of hypoglycaemic substances: hypoglycaemic and hypoketonaemic effects of sodium 2-[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (B 807-27) in fasted animals. Diabetologia. 1982 Jun;22(6):456–463. doi: 10.1007/BF00282590. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES